Weanling PVG/c rats treated with the a-mannosidase inhibitor swainsonine developed increasing proteinuria which terminated as a severe nephrotic syndrome after 35 to 45 days. This was associated with a glomerulopathy characterized by the production of collagen fibrils adjacent to endothelial and mesangial cells, foot process expansion, subepithelial projections of the basement membrane, and splitting of the lamina densa. The swainsonine-induced glomerulopathy appeared to be an exacerbation of a spontaneous abnormality in this strain of rat.
The indolizine alkaloid swainsonine is a potent inhibitor of a-mannosidase in vitro and is capable of inducing a multisystem lysosomal mannoside storage disease in vivo [9, 10, 13, 141 . During experimental studies of induced mannosidosis it was found that young rats of the PVG/c strain developed a severe glomerulopathy and nephrotic syndrome in addition to lysosomal mannoside storage. This was characterized by the accumulation of collagen fibrils which apparently were produced by glomerular endothelial and mesangial cells. This lesion is probably an exacerbation of a spontaneous glomerulopathy in this strain of rat. This paper describes the morphology of the glomerular lesion as detected by light and electron microscopy and discusses possible pathogenetic mechanisms for the development of proteinuria.
Materials and Methods
Pure swainsonine was prepared by solvent extraction of the legume Swuinsonu c'unescen.s [7] . Drinking water containing 10 mg/dl swainsonine was administered ad lihiliim to weanling PVG/c strain rats of both sexes, commencing at 2 I days of age. It was estimated that the rats received an average dose of approximately 12-I5 mg/kg/day for up to 45 days or until severe edema developed. In one experiment 12 treated rats were compared with six age-matched controls in order to study the advanced disease. The treated rats were killed, in pairs, after 29, 35, 37, 38, 42 , and 45 days of treatment, and control pairs were killed on days 30, 35, 40, and 45. The rats were anesthetized by an intraperitoneal injection of pentobarbitone sodium ("Nembutal," Abbott Laboratories, Sydney, Australia) containing 200 IU heparin. They then were perfused via the left ventricle with a solution containing 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. Following perfusion, kidney tissue was sampled for light microscopy and processed routinely for paraffin embedding. A longitudinal section of one entire kidney was prepared from each rat. Three-pm sections were stained with hematoxylin and eosin (HE), Gomori's methenamine silver, periodic acid-Schiff (PAS), Masson's trichrome, Martius scarlet blue, Congo red, and alcian blue. Small blocks ( I mm3) of renal cortex were fixed further in a solution of 1 % osmium tetroxide in the same buffer and processed for epon embedding. One-pm sections were stained with toluidine blue and used to select areas for electron microscopy. At least ten such blocks were examined from each rat. Thin sections were stained with uranyl acetate and lead citrate and examined in an electron microscope. The sampling for electron microscopy was judged to be sufficient to accurately extend the light microscopic observation.
Immediately prior to sacrifice, urine and blood were collected. Total protein was determined, protein electrophoresis was done on urine and serum by standard techniques, and blood urea nitrogen also was assayed. The protein content of urine from all rats was monitored by dipstick analysis.
In a second experiment, five rats were treated with swainsonine for 30 days. During this time they were placed individually in metabolism cages and a six-hour sample of urine was collected daily from each rat for 30 days.
Daily samples were collected similarly from four age-matched controls. Protein content of the urine was determined by standard techniques and the urinary protein output for the six-hour period was calculated. After 30 days the rats were anesthetized and perfused as described.
In a third experiment eight rats were treated for a period of 20 days and then swainsonine was withdrawn from the drinking water. Pairs of rats were anesthetized and perfused on days 10, 2 1, 44, and 70 following the start of treatment. On days 19, 26, 30, 38, 44, 58, and 68 rats were placed in metabolism cages and six-hour urine protein output was determined.
Results
In untreated rats, mesangial nodules which stained as collagen with Masson's trichrome were apparent in at least 50% of glomeruli ( fig. la ). Such nodules were up to approximately 8 pm in diameter and could be located anywhere in the mesangium. They were difficult to detect with HE-stained sections.
Ultrastructural examination of a large number of glomeruli revealed that while most capillary walls and mesangial areas were normal, some abnormalities were present consistently. These were: This was in sharp contrast to the treated rats. When urinary protein output was monitored semi-quantitatively from the initiation of treatment, it was found to rise significantly from the first few days and to increase markedly from about day 20 ( fig. 3 ). By day 30, the daily urinary protein loss was approximately 120 foldabove that of control rats, and between days 35 to 45 all rats became diffusely edematous. In each individual rat the edema advanced over a three-day period, Grossly, the perfused kidneys of treated rats appeared identical to those of control rats, but histologically there was a striking diffuse glomerulopathy. In HE-stained paraffin sections, all glomeruli in rats treated for more than 25 days were abnormal, with large quantities of apparently amorphous eosinophilic material in capillary loops and the mesangium ( fig. 5 ). Occasional pyknotic or fragmented endothelial cell nuclei were present and glomerular cellularity was reduced slightly, although this was not quantified. There were also numerous hyaline casts in the renal tubules. Eosinophilic material in glomeruli failed to react with stains for amyloid, was alcian blue-negative and only slightly PAS-positive. However, it stained intensely as collagen with Masson's trichrome and Martius scarlet blue. Within glomeruli, some segments contained large deposits while others were relatively unaffected. The Martius scarlet blue stain revealed some crescent-shaped subendothelial deposits of material which stained as fibrin. Epon-embedded sections stained with toluidine blue confirmed the presence of abnormal masses of acellular material within glomerular capillary walls, in the mesangium, and often completely occluding capillary loops ( fig. 6 ). In addition, such sections clearly exhibited the lysosomal mannoside storage vacuoles present in endothelial cells of glomeruli and in the proximal tubular epithelial cells.
Ultrastructural examination of the glomerular lesions revealed the acellular deposits to be massive accumulations of fibrillar and amorphous floccular material within the mesangium and capillary loops (fig. 7a) . The fibrillar material had a structure characteristic of collagen with a 64-nm periodicity ( fig. 76) , but the nature of the amorphous material was not determined. Deposits were principally at the axial region of capillary loops but were also around the periphery of loops and frequently appeared to occlude the lumen. Deposits were located between endothelial cytoplasm and the glomerular basement membrane or between ramifying endothelial processes. Endothelial and mesangial cells contained numerous mannoside storage vacuoles and endothelial cell bodies often were displaced from the glomerular basement membrane.
In glomeruli of rats with terminal disease, some individual mesangial and endothelial cells were undergoing necrosis and fragmentation.
Most glomerular epithelial cells contained mannoside storage vacuoles and often the cytoplasm was pale and swollen or contained large numbers of protein absorption granules. In general these conformed to previous descriptions of severe glomerular protein leakage [ 5 ] .
Additional glomerular ultrastructural abnormalities, seen with high frequency in treated rats with advanced disease, included large subepithelial projections of the glomerular basement membrane, large expansions of epithelial foot processes, and splitting of the lamina densa of the glomerular basement membrane. As with collagen deposition, these abnormalities appeared to reflect the marked amplification of a process present in the untreated control rats ( fig. 2 ). Examination of numerous grids led to the conclusion that the frequency of these extra lesions was significantly higher in the swainsonine-treated rats.
The progression of morphologic changes in glomeruli was dificult to assess in the early stages of treatment because of the underlying abnormality in control rats. However, the lesion showed unequivocal intensification at ten days after the initiation of swainsonine treatment, and was severe by 21 days. The rats which were taken off treatment at 20 days continued to excrete large but declining quantities of protein in urine, and did not develop nephrotic edema. Daily protein loss between days 20 and 44 remained consistent at about 50 times that of control rats but fell to about ten fold by day 70 (50 days after cessation of treatment). The glomeruli of these rats still had a high level of the described morphologic abnormalities, but the severity was diminished from those on day 21. All signs of mannoside storage had disappeared by this time.
Discussion
The experiments involving swainsonine treatment originally were aimed at a study of neuronal mannoside-storage disease in various species [ 131. The induction of the nephrotic syndrome in PVG rats was an unforeseen event and has not been duplicated in any other species. In several similar experiments (unpublished) using Sprague-Dawley rats we have been unable to induce either proteinuria or glomerular collagen formation, although renal mannoside storage has been intense.
However, the results of this study show clearly that under the influence of swainsonine large quantities of collagen fibrils are produced in the glomeruli of the PVG/c rat, and this is associated with a marked increase in the permeability of the glomerular filter to plasma protein. The fibrillar material is assumed to be collagen by virtue of its ultrastructural and tinctorial properties. The metabolic disturbance apparently is confined to elements of the glomerulus and is probably an exacerbation of an underlying metabolic peculiarity. It appears to be quite distinct from the spontaneous nephropathy described in the Sprague-Dawley rat [2, 11, 121. Collagen fibrils have been described previously in the mesangium of normal rats, but were sparse and difficult to detect [20] . They also have been recorded in or adjacent to the glomerular basement membrane in human nail-patella syndrome [ 1, 221 and in the mesangium in diabetic glomerulosclerosis, systemic lupus erythematosus, cystinosis, uranium toxicity, and Masugi nephritis [23, 291. However, in none of these conditions has the process been as intense as in the swainsonine-treated rats in which the ultrastructural appearance of glomeruli gave the strong impression, as yet unproven, that the collagen fibrils were being produced by the endothelial and mesangial cells.
The normal basement membrane is known to contain a substantial collagenous component, comprised of types IV and V collagen [8, 171 but with appropriate in vitro manipulation striated collagen fibrils can be demonstrated [4] . The collagen of the glomerular basement membrane is thought to be produced mainly by glomerular epithelial cells but the factors governing its production and turnover are understood poorly [31] and appear difficult to relate to an apparent rapid modulation of endothelial and mesangial cells to virtual fibroblasts. In view of the large quantities of collagen within the endothelium of the glomerular capillaries, one might have expected to see ultrastructural evidence of widespread platelet aggregation and thrombosis, but such was not the case. The Martius scarlet blue stain did reveal some fibrin deposition in rats with terminal disease, but this could not be correlated clearly with ultrastructural findings. The other observed abnormalities also have been recognized in various glomerulopathies. Subendothelial amorphous material has been described in man in hemolytic uremic syndrome [6] and transplant rejection [24, 251 . Epithelial foot process expansion, splitting of the lamina densa of the glomerular basement membrane, and sub-epithelial projections from the glomerular basement membrane are all well-recognized phenomena [6] .
Many types of disease process have been associated with the nephrotic syndrome [ 19,281, but the pathogenetic basis of filtration-barrier malfunction remains poorly understood [ 16, 181. However, three major determinants of barrier function are known to be steric, electrostatic, and hemodynamic factors [3, 15, 2 1, 26, 271. Our results show that filtration-barrier malfunction was expressed very quickly with swainsonine treatment and preceded gross structural distortion of glomeruli, suggesting that the latter had a compounding effect on an initially more subtle disturbance. The possible biochemical basis for such a disturbance is, or course, an intriguing question. Swainsonine is a potent inhibitor not only of lysosomal amannosidase but also of the neutral 0-mannosidases [9] , and it is known now that one of these latter enzymes plays a significant role in the post-translational modification of glycoproteins [30] . It may be the disruption of this activity in glomerular cells that results in the changes reported here. The phenomenon apparently is not related to lysosomal mannoside storage as it never has been reported in genetic mannosidosis of man and cattle [ 141 or in mannosidosis induced by the ingestion of Swainsonu sp by sheep, cattle, and horses [ 141.
Our results also show that the progression of the disease was altered if treatment with swainsonine was stopped after 20 days when there was evidence of regression of proteinurea and structural abnormalities.
This swainsonine-induced glomerulopathy may have potential as a model in experimental nephrology and collagen biochemistry and the results seem to caution against the use of the PVG/c rat in experimental studies of glomerular disease.
